Stroke Certification Less Likely in the Most Disadvantaged Communities
By Elana Gotkine HealthDay Reporter
TUESDAY, July 30, 2024 -- Hospitals located in the most disadvantaged communities have a lower likelihood of adopting any stroke certification, according to a study published online July 25 in JAMA Network Open.
Renee Y. Hsia, M.D., from the University of California in San Francisco, and colleagues conducted a cohort study to examine whether hospitals in socioeconomically disadvantaged communities are less likely to adopt stroke certification using newly collected stroke center data. A total of 5,055 hospitals were studied from 2009 to 2022, of which 47.8, 11.9, and 40.3 percent never achieved stroke certification, were certified as acute stroke-ready hospitals, and were certified as primary stroke centers or higher, respectively.
The researchers found that adoption of any stroke certification was most likely to occur near the most advantaged communities and was least likely near the most disadvantaged communities compared with mixed-advantage communities (hazard ratios, 1.24 and 0.43, respectively). Mixed-advantage communities were most likely to have adoption of acute stroke-ready certification, while adoption of higher-level certification was more likely in the most advantaged communities and least likely in the most disadvantaged communities (hazard ratios, 1.41 and 0.31, respectively). The stroke certification adoption hazard was lower for relatively disadvantaged communities and for the most disadvantaged communities compared with mixed-advantage communities (adjusted hazard ratios, 0.80 and 0.58, respectively), after adjustment for population size and hospital capacity.
"Given increasing evidence showing that stroke-certified hospitals are associated with improved care, incentivizing and providing support for hospitals in disadvantaged communities to obtain stroke certification may serve as an important strategy for reducing stroke disparities," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2024
Read this next
Shorter Leukocyte Telomere Length Linked to Higher Incidence of Age-Related Brain Diseases
THURSDAY, June 12, 2025 -- Individuals with shorter leukocyte telomere length (LTL) have a higher incidence of stroke, dementia, and late-life depression (LLD), individually and...
Talking Therapy Reduces Depression, Anxiety Symptoms in Stroke Survivors
THURSDAY, June 12, 2025 -- For stroke survivors, talking therapy is associated with moderate reductions in depression and large reductions in anxiety symptoms, according to a...
P2Y12 Inhibitor Monotherapy Beneficial for Patients Who Undergo PCI
FRIDAY, June 6, 2025 -- For patients who undergo percutaneous coronary intervention (PCI) and discontinue dual antiplatelet therapy (DAPT), P2Y12 inhibitor monotherapy is...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.